Pyxis Oncology, Inc. (PYXS) Insider Trading

Pyxis Oncology, Inc. (PYXS) has 3 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 8, 2026.

Filings
3
Purchases
0
$0
Sales
0
$0
Insiders
2

Most active PYXS insiders

Civik Thomas
Interim CEO
0 bought · 0 sold · Sept. 8, 2026
$0
Dupont Jakob
Director
0 bought · 0 sold · Aug. 20, 2026
$0

Latest PYXS Form 4 filings

Date Insider Value Shares Stake Pre-planned Links
Sept. 8, 2026 filed Sept. 4, 2026 Civik Thomas CEO & Chairman of the Board $0 2,503,050 0% No
Aug. 20, 2026 Dupont Jakob Director $0 46,000 0% No
Aug. 14, 2026 filed Aug. 12, 2026 Civik Thomas Interim CEO $0 250,956 0% No

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.

Get alerted when PYXS insiders trade

Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.

Start free